Shi Y, Chen J, Yang R, Wu H, et al. Iruplinalkib (WX-0593) versus crizotinib in ALK TKI-naive locally advanced or metastatic ALK-positive non-small cell lung cancer: interim analysis of a randomized, open-label, phase III study (INSPIRE). J Thorac Oncol 2024 Jan 25:S1556-0864(24)00033.
PMID: 38280448